This page is part of the CH IDMP (v1.0.0-ballot: DSTU 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions

• Narrative Content
• XML
• JSON

: PhP Gilteritinibi-hemifumaras-40-Filmtabletten - JSON Representation

Raw json | Download

{
  "resourceType" : "AdministrableProductDefinition",
  "id" : "PhP-Gilteritinibi-hemifumaras-40-Filmcoatedtablet",
  "meta" : {
    "profile" : [
      🔗 "http://fhir.ch/ig/ch-idmp/StructureDefinition/ch-idmp-administrableproductdefinition"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: AdministrableProductDefinition PhP-Gilteritinibi-hemifumaras-40-Filmcoatedtablet</b></p><a name=\"PhP-Gilteritinibi-hemifumaras-40-Filmcoatedtablet\"> </a><a name=\"hcPhP-Gilteritinibi-hemifumaras-40-Filmcoatedtablet\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ch-idmp-administrableproductdefinition.html\">AdministrableProductDefinition</a></p></div><p><b>status</b>: Active</p><p><b>formOf</b>: <a href=\"MedicinalProductDefinition-Xospata-Filmcoatedtablet.html\">MedicinalProductDefinition: extension = Film-coated tablet; identifier = http://fhir.ch/ig/ch-idmp/sid/mpid#Medical Product Identifier#CH-01100869-0672110010000; indication = Xospata wird angewendet für die Behandlung von erwachsenen Patienten, die an rezidivierter oder refraktärer akuter myeloider Leukämie (AML) mit FMS-ähnlichen Tyrosinkinase 3 (FLT3)-Mutationen leiden.; legalStatusOfSupply = A: Single dispensing requiring a medical or veterinary prescription; additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Not authorised for the treatment in children; classification = gilteritinib,Synthetic</a></p><p><b>administrableDoseForm</b>: <span title=\"Codes:{http://standardterms.edqm.eu 10221000}\">Film-coated tablet</span></p><p><b>unitOfPresentation</b>: <span title=\"Codes:{http://standardterms.edqm.eu 15054000}\">Tablet</span></p><h3>RouteOfAdministrations</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://standardterms.edqm.eu 20053000}\">Oral use</span></td></tr></table></div>"
  },
  "status" : "active",
  "formOf" : [
    {
      🔗 "reference" : "MedicinalProductDefinition/Xospata-Filmcoatedtablet"
    }
  ],
  "administrableDoseForm" : {
    "coding" : [
      {
        "system" : "http://standardterms.edqm.eu",
        "code" : "10221000",
        "display" : "Film-coated tablet"
      }
    ]
  },
  "unitOfPresentation" : {
    "coding" : [
      {
        "system" : "http://standardterms.edqm.eu",
        "code" : "15054000",
        "display" : "Tablet"
      }
    ]
  },
  "routeOfAdministration" : [
    {
      "code" : {
        "coding" : [
          {
            "system" : "http://standardterms.edqm.eu",
            "code" : "20053000",
            "display" : "Oral use"
          }
        ]
      }
    }
  ]
}